<VariationArchive RecordType="classified" VariationID="1710487" VariationName="NM_000202.8(IDS):c.1277_1450del (p.Ser426_Asp484delinsTyr)" VariationType="Deletion" Accession="VCV001710487" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-22" DateCreated="2022-10-22" MostRecentSubmission="2022-10-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1708897" VariationID="1710487">
      <GeneList>
        <Gene Symbol="IDS" FullName="iduronate 2-sulfatase" GeneID="3423" HGNC_ID="HGNC:5389" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="149476988" stop="149505306" display_start="149476988" display_stop="149505306" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="148560294" stop="148586883" display_start="148560294" display_stop="148586883" Strand="-" />
          </Location>
          <OMIM>300823</OMIM>
          <Haploinsufficiency last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IDS">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-11-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=IDS">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000202.8(IDS):c.1277_1450del (p.Ser426_Asp484delinsTyr)</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="149482949" stop="149483122" display_start="149482949" display_stop="149483122" variantLength="174" positionVCF="149482948" referenceAlleleVCF="TCTTTTAAACTCGGCTTGTCAGAATTCCACTGAGGGATGTCTGAAGGCCGGGGATACTGGCTATAGGCAATCAGTTCACGGGGATTACCAGGGAGGTACGGATCCTCTTCCAAGTCACGGAATCGAAAATGCTTCAGAAGGTTCTTGCCTTCTCTGCACAGCTCAACGTGAAATG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="148564480" stop="148564653" display_start="148564480" display_stop="148564653" variantLength="174" positionVCF="148564479" referenceAlleleVCF="TCTTTTAAACTCGGCTTGTCAGAATTCCACTGAGGGATGTCTGAAGGCCGGGGATACTGGCTATAGGCAATCAGTTCACGGGGATTACCAGGGAGGTACGGATCCTCTTCCAAGTCACGGAATCGAAAATGCTTCAGAAGGTTCTTGCCTTCTCTGCACAGCTCAACGTGAAATG" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.148564480_148564653del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.148564480_148564653del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.149482949_149483122del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.149482949_149483122del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011900.3" sequenceAccession="NG_011900" sequenceVersion="3" change="g.27213_27386del">
            <Expression>NG_011900.3:g.27213_27386del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000202.8" sequenceAccession="NM_000202" sequenceVersion="8" change="c.1277_1450del" MANESelect="true">
            <Expression>NM_000202.8:c.1277_1450del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000193.1" sequenceAccession="NP_000193" sequenceVersion="1" change="p.Ser426_Asp484delinsTyr">
            <Expression>NP_000193.1:p.Ser426_Asp484delinsTyr</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001820" Type="inframe_indel" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166550.4" sequenceAccession="NM_001166550" sequenceVersion="4" change="c.1007_1180del">
            <Expression>NM_001166550.4:c.1007_1180del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001160022.1" sequenceAccession="NP_001160022" sequenceVersion="1" change="p.Ser336_Asp394delinsTyr">
            <Expression>NP_001160022.1:p.Ser336_Asp394delinsTyr</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001820" Type="inframe_indel" DB="SO" />
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000202.8(IDS):c.1277_1450del (p.Ser426_Asp484delinsTyr) AND Mucopolysaccharidosis, MPS-II" Accession="RCV002291494" Version="1">
        <ClassifiedConditionList TraitSetID="2973">
          <ClassifiedCondition DB="MedGen" ID="C0026705">Mucopolysaccharidosis, MPS-II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-22" MostRecentSubmission="2022-10-22">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="2973" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10834" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Attenuated MPS (subtype; formerly known as mild MPS II)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Severe MPS II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Iduronate 2-sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">I2S deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hunter Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IDS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfoiduronate sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SIDS deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis with skin involvement</ElementValue>
                <XRef ID="MONDO:0019302" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-II</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+II/4913" DB="Genetic Alliance" />
                <XRef ID="70737009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type 2</ElementValue>
                <XRef ID="MONDO:0010674" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MPS II</ElementValue>
                <XRef Type="MIM" ID="309900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">MPS2</ElementValue>
                <XRef Type="MIM" ID="309900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type II (MPS II; also known as Hunter syndrome) is an X-linked multisystem disorder characterized by glycosaminoglycan (GAG) accumulation. The vast majority of affected individuals are male; on rare occasion heterozygous females manifest findings. Age of onset, disease severity, and rate of progression vary significantly among affected males. In those with early progressive disease, CNS involvement (manifest primarily by progressive cognitive deterioration), progressive airway disease, and cardiac disease usually result in death in the first or second decade of life. In those with slowly progressive disease, the CNS is not (or is minimally) affected, although the effect of GAG accumulation on other organ systems may be early progressive to the same degree as in those who have progressive cognitive decline. Survival into the early adult years with normal intelligence is common in the slowly progressing form of the disease. Additional findings in both forms of MPS II include: short stature; macrocephaly with or without communicating hydrocephalus; macroglossia; hoarse voice; conductive and sensorineural hearing loss; hepatosplenomegaly; dysostosis multiplex; spinal stenosis; and carpal tunnel syndrome.</Attribute>
                <XRef ID="NBK1274" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301451</ID>
                <ID Source="BookShelf">NBK1274</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21863056</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Giugliani et al., 2014">
                <ID Source="PubMed">25071396</ID>
              </Citation>
              <XRef ID="580" DB="Orphanet" />
              <XRef ID="79388" DB="Orphanet" />
              <XRef ID="C0026705" DB="MedGen" />
              <XRef ID="MONDO:0010674" DB="MONDO" />
              <XRef Type="MIM" ID="309900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5049366" SubmissionDate="2022-10-13" DateLastUpdated="2022-10-22" DateCreated="2022-10-22">
        <ClinVarSubmissionID localKey="SUB12148395" submittedAssembly="GRCh38" title="SUB12148395" />
        <ClinVarAccession Accession="SCV002583240" DateUpdated="2022-10-22" DateCreated="2022-10-22" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variant has shown hemizygous deletion of c.1007_1180del in exon 8 of IDS gene. This variant is not reported in 1000 genomes and gnomAD databases.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage on the Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication. Experimental observations</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Hemizygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000280" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0012736" />
              </Trait>
              <Comment>Dysostosis multiplex, organomegaly</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="IDS">
              <Name>iduronate 2-sulfatase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001166550.4:exon 8</GeneLocation>
          </Location>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_001166550.4:c.1007_1180del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="309900" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12148395</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5049366" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012736" MappingRef="HP">
        <MedGen CUI="C3553450" Name="Profound global developmental delay" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049366" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000280" MappingRef="HP">
        <MedGen CUI="C1845847" Name="Coarse facial features" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5049366" TraitType="Disease" MappingType="XRef" MappingValue="309900" MappingRef="OMIM">
        <MedGen CUI="C0026705" Name="Mucopolysaccharidosis, MPS-II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

